Billionaire Druckenmiller’s 5 Stocks Picks with Huge Upside Potential

Page 5 of 5

1. AbCellera Biologics Inc. (NASDAQ:ABCL)

Duquesne Capital’s Equity Stake: $3.04 Million
Share Price Upside Potential: 417.24%
Number of Hedge Fund Holders: 17

AbCellera Biologics Inc. (NASDAQ:ABCL) is billionaire Druckenmiller’s top stock pick with tremendous upside potential with operations in the healthcare sector. AbCellera Biologics Inc. (NASDAQ: ABCL) values its research collaboration and license agreement with Eli Lilly.

Druckenmiller has held stakes in AbCellera Biologics Inc. (NASDAQ:ABCL) since the fourth quarter of last year at the height of the bear run. Duquesne Capital held stakes worth $3 million in the company in Q3 2023, accounting for 0.1% of the portfolio. While AbCellera Biologics Inc. (NASDAQ:ABCL) is down by about 52%, analysts on Wall Street are bullish about its prospects, with a $24 price target implying a 417.24% upside potential.

In the third quarter of 2023, 17 hedge funds had stakes in AbCellera Biologics Inc. (NASDAQ:ABCL), according to Insider Monkey’s database. Baker Bros. Advisors, led by Julian Baker and Felix Baker, was the leading stakeholder in the company.

Follow Abcellera Biologics Inc. (NASDAQ:ABCL)

[/company-follow-email]

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily newsletter to get  the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also check out our articles on 15 Stocks under $50 to Buy and Hold Forever and Billionaire Daniel Sundheim’s D1 Capital Portfolio: Top 12 Stock Picks.

Page 5 of 5